Correlation Between BigBearai Holdings and Santen Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BigBearai Holdings and Santen Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BigBearai Holdings and Santen Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BigBearai Holdings and Santen Pharmaceutical Co, you can compare the effects of market volatilities on BigBearai Holdings and Santen Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BigBearai Holdings with a short position of Santen Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of BigBearai Holdings and Santen Pharmaceutical.

Diversification Opportunities for BigBearai Holdings and Santen Pharmaceutical

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between BigBearai and Santen is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding BigBearai Holdings and Santen Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santen Pharmaceutical and BigBearai Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BigBearai Holdings are associated (or correlated) with Santen Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santen Pharmaceutical has no effect on the direction of BigBearai Holdings i.e., BigBearai Holdings and Santen Pharmaceutical go up and down completely randomly.

Pair Corralation between BigBearai Holdings and Santen Pharmaceutical

Given the investment horizon of 90 days BigBearai Holdings is expected to generate 8.83 times more return on investment than Santen Pharmaceutical. However, BigBearai Holdings is 8.83 times more volatile than Santen Pharmaceutical Co. It trades about 0.18 of its potential returns per unit of risk. Santen Pharmaceutical Co is currently generating about -0.22 per unit of risk. If you would invest  338.00  in BigBearai Holdings on October 7, 2024 and sell it today you would earn a total of  115.00  from holding BigBearai Holdings or generate 34.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

BigBearai Holdings  vs.  Santen Pharmaceutical Co

 Performance 
       Timeline  
BigBearai Holdings 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in BigBearai Holdings are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, BigBearai Holdings demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Santen Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Santen Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Santen Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

BigBearai Holdings and Santen Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BigBearai Holdings and Santen Pharmaceutical

The main advantage of trading using opposite BigBearai Holdings and Santen Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BigBearai Holdings position performs unexpectedly, Santen Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santen Pharmaceutical will offset losses from the drop in Santen Pharmaceutical's long position.
The idea behind BigBearai Holdings and Santen Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA